Increased Risk of Retinal Vasculitis May Be Associated with Aflibercept 8 mg: A Pharmacovigilance Analysis of the FAERS Database
This study identified a safety signal indicating a possible increased risk of retinal vasculitis with aflibercept 8 mg compared to the conventional 2 mg dose. This finding requires confirmation through future postmarketing studies.
Authors
- M. Hossein Nowroozzadeh (ORCID: https://orcid.org/0000-0002-7412-1900)
- Maryam Hajipourkhorasani
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1080/09273948.2025.2476061
- Citations
- 4
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 6.83